Image pharmaphorum Editor Market Access Sponsored Innovative contracting in Europe – a Trojan horse? Overview Debates & Insight Sponsored How to optimise pharma’s digital HCP engagement Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a compan Views & Analysis Metrics to Meaning: mapping the path to better communication... Success is something we all want to achieve, but without specific measures in place it becomes an abstract concept. Views & Analysis The rise and rise of digital health investment From remote consultations to digital treatments, medical robotics to wellness apps, the digital health ecosystem is expanding like never before. Load more results
Debates & Insight Sponsored How to optimise pharma’s digital HCP engagement Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a compan
Views & Analysis Metrics to Meaning: mapping the path to better communication... Success is something we all want to achieve, but without specific measures in place it becomes an abstract concept.
Views & Analysis The rise and rise of digital health investment From remote consultations to digital treatments, medical robotics to wellness apps, the digital health ecosystem is expanding like never before.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
